Optometrists in Beeville, TX Accepting Medicare
4 Optometrists found. Showing 1 - 4
 Dr. Kavita Mistry Optometrist Medicare: Not Enrolled in Medicare Practice Location: 502 E Fm 351, Beeville, TX 78102 Phone: 361-362-1666 |
 Bronte D Baker Od Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1209 N St Marys Street, Beeville, TX 78102 Phone: 361-358-3218 Fax: 361-358-3281 |
Mira Vision Boutique Optometrist Medicare: Medicare Enrolled Practice Location: 701 E Houston St, Beeville, TX 78102 Phone: 361-362-2020 Fax: 361-362-2030 |
Kavita Mistry O.d.,p.a Optometrist Medicare: Not Enrolled in Medicare Practice Location: 502 E Fm 351, Beeville, TX 78102 Phone: 361-362-1666 Fax: 361-362-1163 |
News Archive
PrimeEnterprise community healthcare IT solution launched by Greenway Medical Technologies
Greenway Medical Technologies Inc. recently announced the launch of its community healthcare IT solution, PrimeEnterprise, which enables a community of Greenway((R)) customers to securely and seamlessly share select clinical, financial and administrative data.
Mental health, substance abuse spending grew more slowly than all other health spending: Study
Spending on psychiatric drugs grew by 5.6 percent from 2004 to 2005, down from the 27.3 percent growth from 1999 to 2000 according to a study published today in the February issue of Health Affairs.
Johns Hopkins members to be honored with American Academy of Nursing's Fellows recognition
Faculty members at the Johns Hopkins School of Nursing will be honored in all three categories of the American Academy of Nursing's Fellows recognition. Sharon Kozachik, PhD, RN, and Jennifer Wenzel, PhD, RN, CCM, will be inducted as Fellows, Laura Gitlin, PhD, will be awarded an Honorary fellowship, and Fannie Gaston-Johansson, PhD, RN, FAAN, will be recognized as a Living Legend—the academy's highest distinction.
Cascade Chemistry selected to help speed clinical testing of promising investigational drug for COVID-19
Cascade Chemistry, a leading contract research and manufacturing organization serving the pharmaceutical, materials, and chemical industries, today announced that it has been selected to produce the active pharmaceutical ingredient for clinical trial supplies of RBT-9, an investigational therapy entering a Phase 2 trial for the treatment of COVID-19 patients who are at high risk of deteriorating health due to age or comorbid conditions such as kidney or cardiovascular disease.
In-home breathing device may offer hope for people with COPD
In a new paper published Feb. 4 in JAMA, Mayo Clinic researchers describe the benefits of in-home noninvasive ventilation therapy- which includes a type referred to as bilevel positive airway pressure, or BiPAP- for many patients with chronic obstructive pulmonary disease.
› Verified 9 days ago
Speech-Language Pathologists
Physical Therapists
Chiropractors
Optometrists